Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
JYNNEOS vaccine coverage remains highly variable across jurisdictions with low uptake of the second dosage, as of November 2023 data.News Article updated on 01/08/2024
-
Kern County Rapid ART
Kern County Rapid ART links people with a new diagnosis of HIV to ART. The Kern County Health Officer’s Clinic identifies people with a new diagnosis of HIV through onsite testing, surveillance data, and referrals from local hospital emergency departments. Kern County Rapid ART provides support services and refers clients to other community clinics for ongoing care. A study of clients with a new diagnosis of HIV in 2021 found that on average, Kern County Rapid ART clients were linked to care and provided ART within two days of diagnosis.Resource from the RWHAP Best Practices Compilation updated on 01/24/2024
-
Increasing Viral Suppression for MSM of Color
A broad population of men who have sex with men (MSM) reached viral suppression through intensive case management by applying tools and lessons learned in the Center for Quality Improvement Innovation end+disparities ECHO Collaborative.Resource from the RWHAP Best Practices Compilation updated on 11/24/2023
-
Tech/Mobile Apps Supporting HIV Care
Technology-focused tools to support HIV care engagement.Blog updated 04/10/2023
-
Designing and Conducting a Culturally Responsive Evaluation (CRE) of the SPNS BMSM Initiative
The Implementation of Evidence-Informed Behavioral Health Models to Improve HIV Health Outcomes for the BMSM Initiative seeks to engage, link, and retain black men who have sex with men in HIV medical care, behavioral health care, and supportive services. This session will describe the use of the Culturally Responsive Evaluation (CRE) framework to evaluate the initiative.
Resource (Conference Presentation) updated 09/14/2023
-
NIH Center Efforts Towards the EHE Initiative: Innovative Partnerships to Implement New Tools
Implementation of innovations for End the HIV Epidemic (EHE) efforts requires innovative research/community collaborations. This session presents LA County’s efforts to prepare for long-acting injectable treatment, Miami’s pilot of telemedicine for test-and-treat at a syringe services program, and Philadelphia’s partnership to evaluate a U=U campaign.
Resource (Conference Presentation) updated 09/14/2023
-
Using Innovative Technology Strategies to Engage BMSM with HIV in Care
Three sites in the Special Projects of National Significance Black Men Who Have Sex with Men (BMSM) Initiative have developed and implemented innovative technology innovations to engage BMSM in care. These include apps, telemedicine, social media, and texting services that meet clients where they are and provide access to services. This presentation will describe product selection and early implementation experiences.
Resource (Conference Presentation) updated 09/14/2023
-
Updates from Recent HIV Research Conferences: CROI 2020 and AIDS 2020
Review of research insights from two major HIV conferences held in 2020.Resource (Conference Presentation) updated 09/14/2023
-
New and Investigational ART Drugs and Strategies
Review of antiretroviral regimens in the clinical trials phase.Resource (Conference Presentation) updated 09/14/2023
-
Treating HIV in 2020: Interactive Cases From the Clinic(ians) and Panel Discussion
Case examples of starting antiretroviral therapy in patients under varied scenarios.Resource (Conference Presentation) updated 09/14/2023
-
Rapid ART Dissemination Assistance Provider
Project to facilitate the implementation of Rapid ART initiation in RWHAP provider settings by compiling and disseminating implementation resources nationwide. Project period: 2020-2023.RWHAP Technical Assistance Provider updated on 03/04/2024
-
His Health: Innovation - Sexual Health Services/Consumer Advisory Board
A sexual health clinic focused on HIV testing and linkage to care for young MSM of color.Resource updated 09/19/2023
-
Eligibility for Simplification of HIV Salvage Regimens Based on Genotypic
Resource (Conference Presentation) updated 09/14/2023
-
Clinical and Behavioral Health Integration for BMSM Living With HIV
Resource (Conference Presentation) updated 09/14/2023
-
A Qualitative Approach to Understanding the Mental Health Needs of Black MSM Living With HIV
Resource (Conference Presentation) updated 09/14/2023
-
Adolescent Viral Load Suppression: Challenges and Success Stories
Resource (Conference Presentation) updated 09/14/2023
-
Average Time to Initiation of Antiretroviral Therapy - Newly Diagnosed HIV Patients - University of Utah
Resource (Conference Presentation) updated 09/14/2023
-
Rapid Access of Initial HIV Appointment and ART Prescription
Resource (Conference Presentation) updated 09/14/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023